Pfizer confirmed that it is in the process of exploring immunity after vaccination with intense research.
A route which requires observing a large number of people who have had the disease once until some get it a second time.
MORE IN PANORAMA PRINT EDITION
16-02-21 PANORAMAdailyGIBRALTAR